Hypertension in an animal model of polycystic kidney disease is not dependent on the short-term actions of endogenous tumour necrosis factor-α in the subfornical organ
thesisposted on 2022-03-28, 17:39 authored by Monique Van Acquoy
The development of hypertension in an animal model of polycystic kidney disease, the Lewis polycystic kidney (LPK) rat, is caused, in part, by the overactivation of the subfornical organ (SFO). Circulating proinflammatory cytokines, namely tumour necrosis factor-α (TNFα), are suggested to act in the central nervous system to produce an increase in neuronal excitability. Therefore, we hypothesised that TNFα acts on the SFO to increase neuronal activity, therefore contributing to the development of hypertension. Urethane-anaesthetised Lewis control (n=20 total) and LPK (n=19 total) animals underwent microinjections of TNFα or tumour necrosis factor receptor 1 antibody (TNFRI Ab) or minocycline, an inhibitor of microglial activation, followed by a GABAa agonist into the SFO. Microglial activation in the SFO was assessed by staining with an anti-Iba1 antibody (n=2 Lewis and n=3 LPK). Microinjection of TNFα into the SFO led to a dose-dependent increase in mean arterial pressure (MAP) in Lewis animals (P0.05). Minocycline microinjection did not reduce MAP in Lewis or LPK animals (-1 ± 1 mmHg vs -1 ± 1 mmHg, Lewis vs LPK, P>0.05). Microinjection of minocycline in LPK animals significantly increased the tonic activation of the SFO, indicated by the increased depressor response to GABAa agonist microinjection (-12 ± 2 mmHg vs -23 ± 4 mmHg, no inhibitor vs prior minocycline microinjection, P=0.04). Preliminary observation suggests that LPK animals have considerably more activated microglia than Lewis animals. Overall, these findings demonstrate that proinflammatory cytokines in the SFO do not contribute to the short-term control of BP in normotensive conditions and do not contribute to the overactivation and therefore the development of hypertension in LPK animals -- abstract.